Puma Biotechnology Inc.

3.04
0.06 (2.01%)
At close: Jan 28, 2025, 3:59 PM
2.93
-3.68%
After-hours Jan 28, 2025, 05:41 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07
Net Income 21.59M 2.00K -29.13M -59.99M -75.59M -113.58M -291.95M -276.01M -239.28M -141.97M -54.66M -74.35M -10.23M -15.98K -16.84K -14.08K -15.09M
Depreciation & Amortization 11.52M 8.92M 10.60M 10.03M 8.08M 7.38M 2.81M 1.15M 776.00K 627.00K 423.00K 265.00K 10.70K n/a n/a n/a n/a
Stock-Based Compensation 10.25M 11.83M 32.63M 36.58M 57.33M 86.94M 108.73M 117.26M 94.93M 39.15M 7.52M 1.41M n/a n/a n/a n/a n/a
Other Working Capital -18.30M -33.60M 9.94M 18.20M 33.48M 13.56M 11.98M 10.31M -13.88M 20.49M -18.54M 9.59M -281.10K n/a n/a n/a n/a
Other Non-Cash Items 1.51M 7.03M 7.20M 1.03M 9.31M 289.00K -30.00K 3.37M 179.00K 192.00K 10.21M 18.69M 8.09M -15.98K -16.84K -14.08K -1.41M
Deferred Income Tax n/a n/a n/a n/a n/a 5.00K n/a -10.00K -32.00K 3.00K n/a 12.00K n/a n/a n/a n/a n/a
Change in Working Capital -17.85M -43.58M -602.00K 13.16M 23.28M -5.14M 7.94M 12.54M -11.07M 24.79M -8.33M 9.98M 305.12K -2.27K 21.00 2.25K 1.41M
Operating Cash Flow 27.01M -15.80M 20.70M 800.00K 22.40M -24.10M -172.50M -141.70M -154.50M -77.20M -55.05M -44.00M -1.83M -18.25K -16.82K -11.83K -15.09M
Capital Expenditures -12.64M -7.00M n/a -20.05M -306.00K -609.00K -50.43M -7.28M -1.18M -1.29M -628.00K -1.06M -692.75K n/a n/a n/a n/a
Acquisitions n/a n/a n/a 20.00M n/a 193.00K 36.00K 15.00K -37.00K -25.00K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -23.81M -4.84M -38.07M -29.83M -127.20M -107.50M -79.73M -81.79M -214.81M -132.26M -49.35M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments 17.33M 18.94M 27.19M 73.28M 132.67M 50.49M 114.72M 231.27M 133.22M 70.28M 8.45M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies -12.50M -4.00K -19.00K -20.10M 37.00K -170.00K -15.01M -4.00K -3.10M -1K -2.00K -138.00K -1.05M n/a n/a n/a n/a
Investing Cash Flow -19.13M 7.10M -10.90M 23.30M 5.20M -57.60M -15.40M 142.20M -85.90M -63.30M -41.53M -1.20M -1.75M n/a n/a n/a n/a
Debt Repayment n/a n/a -1.50M n/a -60.63M 105.00M 50.00M n/a n/a n/a n/a n/a 150.00K n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a -277.00K -30.43M 68.00K -6.44M 3.45M 25.11M 576.00K 28.23M 6.53M 2.21M 45.00K 61.79K 16.30K n/a n/a 16.50M
Financial Cash Flow n/a 12.20M -31.90M 100.00K -67.10M 108.40M 75.10M 162.40M 233.36M 136.00M 2.21M 129.30M 56.95M 16.30K 19.15K 10.50K 16.50M
Net Cash Flow 7.88M 3.50M -22.16M 24.24M -39.53M 26.72M -112.80M 162.93M -6.97M -4.50M -94.36M 84.03M 56.95M -1.95K 2.33K -1.33K 1.41M
Free Cash Flow 14.37M -22.80M 20.70M -19.25M 22.09M -24.71M -222.93M -148.98M -155.68M -78.49M -55.68M -45.06M -2.52M -18.25K -16.82K -11.83K -15.09M